Hats off to Dr. Darren Feldman and the Alliance for Clinical Trials in Oncology A031102 (TIGER) study team, collaborators, and the patients who made this significant milestone happen! EORTC Movember USA ANZUP #NCI #NCTN

So proud of my friends an colleagues Alicia Morgans, MD, MPH and Narjust Florez (Duma), M.D. for their appointments and of course making the DFCI E-news! Dana-Farber Lank Center for Genitourinary Oncology @DanaFarber #WomenInMedicine

Immunotherapy-Based Combinations Remain the Focus of Frontline Treatment in Metastatic RCC Rana McKay Stephanie Berg Michael Schweizer UC San Diego Health Moores Cancer Center Dana-Farber City of Hope Washington U. Med Kaiser Permanente OncLive SOSS #pcsm #kcsm #OncLiveIPC
ow.ly/Ofcp50LgXqG

TWO WEEKS until #IKCSNA22 kicks off with our welcome reception and first-time attendee happy hour! Re-share and tag a #kidneycancer colleague you're excited to see in Austin on November 4-5! (there's still time to register here: bit.ly/3xemToY)

Great day for the Zoo! Dana-Farber Dana-Farber_GU Stephanie Berg #Bostonlights #danafarber75 Zoo New England

Proud to be a part of this amazing institution. Celebrating 75 years! Zoo New England #DanaFarber75 Dana-Farber Lank Center for Genitourinary Oncology Dana-Farber Lank Center for Genitourinary Oncology

Multi center real world work by Justine Panian Rana McKay paving way for S1931 PROBE ! Ulka Vaishampayan SWOG Cancer Research Network #KCRS22 KidneyCAN

We take this pic every year at #KCRS , and this year, we had to switch up locations to accommodate our growing group of folks working to #acceleratecures for #kidneycancer . What an incredible honor to bring all these brains together!

#KCRS 22 OncoAlert

Great discussion thus far second day highlighting our first line trial, PDIGREE (A031704) Tian Zhang, MD, MHS Alliance for Clinical Trials in Oncology open and enroll! Dana-Farber Lank Center for Genitourinary Oncology Sumanta Pal Brian Rini, MD Toni Choueiri, MD Rana McKay Tom Powles Laurence Albiges KidneyCAN #KCRS22

This #kidneycancer powerhouse on stage means serious business first thing. Brian Rini, MD Toni Choueiri, MD Sumanta Pal Laurence Albiges Martin Voss Rana McKay — Day 2 starts #KCRS22 KidneyCAN

The one and only Bradley McGregor Dana-Farber Lank Center for Genitourinary Oncology with the phase 2 CaNI trial of cabozantinib + nivolumab + ipilimumab in variant histology #RCC

KidneyCAN OncoAlert

A031801: Cabo vs Cabo + radium in any RCC histology presented at #KCRS22 presented by Rana McKay Alliance for Clinical Trials in Oncology now enrolling ! Toni Choueiri, MD

Wonderful discussions and presentations during session 2 bench to bedside! #KCRS22 Tian Zhang, MD, MHS Neeraj Agarwal Dana-Farber Lank Center for Genitourinary Oncology Toni Choueiri, MD Sumanta Pal Rana McKay Bradley McGregor

Dr. Monica Bertagnolli begins her role as the 16th Director of the National Cancer Institute effective today, Monday, October 3, 2022. Tweets posted from this account hereafter will be hers.

As we gear up for #KCRS22 , a special shout out to the stellar Abstract Committee who helped us put together a star-studded program of #kidneycancer researchers!

Abstracts: bit.ly/3xXt7e0
FREE virtual registration: kcrs.kidneycan.org

OncoAlert OncLive.com UroToday.com